Norges Bank’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $842K | Buy |
+72,674
| New | +$842K | ﹤0.01% | 1568 |
|
|
2025
Q1 | – | Sell |
-91,579
| Closed | -$1.32M | – | 1576 |
|
|
2024
Q4 | $1.32M | Buy |
+91,579
| New | +$1.32M | ﹤0.01% | 1729 |
|
|
2024
Q3 | – | Sell |
-991,051
| Closed | -$19.3M | – | 1651 |
|
|
2024
Q2 | $19.3M | Buy |
991,051
+116,060
| +13% | +$2.26M | ﹤0.01% | 1224 |
|
|
2024
Q1 | $32.8M | Buy |
874,991
+226,995
| +35% | +$8.52M | 0.01% | 1110 |
|
|
2023
Q4 | $36.3M | Buy |
647,996
+360,498
| +125% | +$20.2M | 0.01% | 1050 |
|
|
2023
Q3 | $11.9M | Sell |
287,498
-293,046
| -50% | -$12.1M | ﹤0.01% | 1403 |
|
|
2023
Q2 | $32.4M | Sell |
580,544
-176,096
| -23% | -$9.83M | 0.01% | 1057 |
|
|
2023
Q1 | $42.2M | Sell |
756,640
-138,407
| -15% | -$7.72M | 0.01% | 914 |
|
|
2022
Q4 | $32.6M | Buy |
895,047
+85,712
| +11% | +$3.12M | 0.01% | 1026 |
|
|
2022
Q3 | $23M | Buy |
809,335
+87,706
| +12% | +$2.5M | 0.01% | 1139 |
|
|
2022
Q2 | $32.7M | Buy |
721,629
+4,761
| +0.7% | +$215K | 0.01% | 991 |
|
|
2022
Q1 | $54.5M | Sell |
716,868
-18,883
| -3% | -$1.44M | 0.01% | 831 |
|
|
2021
Q4 | $110M | Sell |
735,751
-9,655
| -1% | -$1.44M | 0.02% | 574 |
|
|
2021
Q3 | $109M | Buy |
745,406
+82,713
| +12% | +$12M | 0.02% | 583 |
|
|
2021
Q2 | $130M | Buy |
662,693
+229,846
| +53% | +$45M | 0.03% | 547 |
|
|
2021
Q1 | $78.3M | Buy |
+432,847
| New | +$78.3M | 0.02% | 738 |
|
|
2020
Q4 | – | Sell |
-20,000
| Closed | -$2.49M | – | 2163 |
|
|
2020
Q3 | $2.49M | Hold |
20,000
| – | – | ﹤0.01% | 1947 |
|
|
2020
Q2 | $1.79M | Hold |
20,000
| – | – | ﹤0.01% | 1970 |
|
|
2020
Q1 | $1.25M | Hold |
20,000
| – | – | ﹤0.01% | 1962 |
|
|
2019
Q4 | $1.53M | Hold |
20,000
| – | – | ﹤0.01% | 2000 |
|
|
2019
Q3 | $1.01M | Buy |
+20,000
| New | +$1.01M | ﹤0.01% | 2035 |
|